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ABSTRACT Multisite protein phosphorylation and dephosphorylation are key cellular regulatory mechanisms but their system
properties have been difﬁcult to study in vivo and in vitro. Here we show by mathematical analysis that steady-state invariants
enable themechanism of the kinase or the phosphatase to be determined from steady-statemeasurements. Invariants exist when
both enzymesact distributively (i.e., nonprocessively),making atmost onemodiﬁcation in eachmolecular encounter. For instance,
in the sequential case, in any experiment involving the same ingredients, the quantity [Si1][Si11]/[Si]
2 always has the same value,
where [Si] denotes the steady-state concentration of the i-th phospho-form. For a two-site substrate, if either enzyme exhibits
processivity, so that more than one modiﬁcation can be made in each molecular encounter, the degree of processivity can be
estimated from changes in this invariant. We discuss the experimental and theoretical challenges in extending these results.
INTRODUCTION
Ever since the discovery of reversible protein phosphory-
lation (1), its importance as a key cellular regulatory mech-
anism has been increasingly appreciated (2). Disregulation of
phosphorylation is implicated in several human diseases and
both kinase and phosphatase inhibitors are important in the
clinic (3,4). Prokaryotes predominantly use two-component
histidine, aspartate phospho-transfer, whereas eukaryotes
predominantly rely on serine, threonine, and tyrosine phos-
phorylation (5–7). Signiﬁcantly, eukaryotes exhibit a strik-
ing difference in multisite modiﬁcation (8,9). Bacterial and
archaeal proteins are phosphorylated on at most a few sites
under normal conditions (10,11), whereas eukaryotic proteins
can be heavily phosphorylated (7): p53, which integrates the
cell’s DNA damage response, has 16 phosphorylation sites,
targeted by several kinases and phosphatases (9).
A substrate molecule with n phosphorylation sites may be
in one of 2n states and a population of molecules may contain
a mixture of these different phospho-forms. Furthermore, the
system of kinases, phosphatases, and substrate is maintained
far from equilibrium in vivo by a steady supply of ATP. This
is a recipe for complex emergent behavior but this has rarely
been seen either in vivo or in vitro. In vivo studies are ham-
pered by the need for single-cell resolution and the absence
of real-time sensors for phosphorylation state. In vitro stud-
ies are normally done with either kinase or phosphatase.
Recent exceptions to this have been the development of
extract systems for phosphorylation studies (12) and the
remarkable in vitro recapitulation of the cyanobacterial cir-
cadian oscillator (13), which manifests itself as an oscillation
in multisite phosphorylation. These experimental studies hint
at the complexity that is to be found with just three com-
ponents: kinase, phosphatase, and substrate.
Despite their dynamical complexity, such systems can
satisfy algebraic invariants at steady state. Invariants are
algebraic expressions, which only involve measurable state
variables, whose values are independent of the conditions
under which the system is initiated, such as the total amounts
of enzymes or substrate (Eq. 5). We show here that these in-
variants provide a method for determining the mechanism of
action of both kinases and phosphatases. This method has many
advantages over current techniques, as summarized in the
Discussion.
We consider a kinase E and phosphatase F acting on a
substrate S with n phosphorylation sites. The enzymes are
initially assumed to act distributively on S and to maintain a
sequential order of phosphorylation. Distributivity means that
at most one modiﬁcation (addition or removal of phosphate)
takes place in each encounter between substrate molecule
and enzyme molecule (14). Accordingly, each phospho-form
competes for both enzymes. Sequentiality means that sites
are phosphorylated in a speciﬁc order and dephosphorylated
in the reverse order, so that there are only n 1 1 phospho-
forms, S0,   , Sn. Here, Si denotes the phospho-form with
i sites phosphorylated in order. These assumptions give rise
to a chain of reactions
S0 EF S1 
E
F
   E
F
Sn: (1)
The enzymes are assumed to operate through a standard
biochemical reaction scheme with reversible formation of an
enzyme-substrate complex and irreversible formation of
product:
X1 Si 
a
X
i
b
X
i
XS/
c
X
i
X1 Si61: (2)
Here, X ¼ E, 0 # i , n and the product is Si11, or, X ¼ F,
0 , i # n and the product is Si1. Assuming mass-action
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kinetics, the reactions are labeled with their corresponding
rate constants (‘‘a’’ for association, ‘‘b’’ for breakup, and
‘‘c’’ for catalysis), with the subscript corresponding to the
substrate of the reaction.
These assumptions are frequently used for multisite phos-
phorylation (14,15) although Eq. 2 is sometimes approxi-
mated by a Michaelis-Menten rate function (16–18). We
make no approximations here. The relevance of our assump-
tions to current experimental understanding is reviewed in
the Discussion.
Equations 1 and 2 give rise to a (3n 1 3)-dimensional
dynamical system in which the state variables are the con-
centrations of the n 1 1 phospho-forms, S0,    Sn; the 2n
enzyme-substrate complexes, ESi for 0 # i , n and FSj for
0 , j # n; and the two free enzymes, E and F. As modeled,
the system is closed; ATP is assumed to be held constant,
through a mechanism that is not explicitly modeled, and its
effects absorbed into the rate constants. It follows, assuming
a ﬁxed reaction volume, that the total concentrations of sub-
strate, [Stot], and enzymes, [Etot] and [Ftot], remain constant
during any time evolution of the system. When started from
some initial condition, the system would be expected to relax
onto a stable steady state, in which the actions of the kinase
and the phosphatase are in balance. Although it contains no
explicit feedback, the system can exhibit multistability: there
may be more than one steady state having the same total
amounts of substrate and enzymes (17). Indeed, the maximal
number of steady states increases with n (M. Thomson and
J. Gunawardena, unpublished data).
Although this dynamical system is nonlinear, there is an
analytic solution for it at steady state. We review this below
but its main consequence is that, if [] denotes concentration
in any steady state,
½Si11
½Si ¼ li
½E
½F for 0 # i , n: (3)
Here, using the notation introduced in Eq. 2, li is the site-
speciﬁc relative catalytic efﬁciency,
li ¼ c
E
i
K
E
i
 
cFi11
K
F
i11
 1
; (4)
and KXi is the site-speciﬁc Michaelis-Menten constant for
X ¼ E or X ¼ F, KXi ¼ ðbXi 1cXi Þ=aXi :
Equation 3 has the following remarkable consequence.
Dividing the formulas for i 1 1 by that for i, we see that
½Si1½Si11
½Si2
¼ li
li1
: (5)
The left-hand side of Eq. 5 depends only on the measur-
able state variables, S0,   , Sn, whereas the right-hand side
depends only on the rate constants. Hence, in any experiment
involving the same ingredients, no matter what amounts are
used, no matter how the system is started and no matter what
steady state is reached, the left-hand side must always have
the same value. We refer to such quantities as invariants
of the system. (There are further invariants of the form
[Si11][Sj]/([Si][Sj11]) but these can be written in terms of
those in Eq. 5.)
The main focus of this article is to ask what happens when
Eq. 5 is not satisﬁed. One of the key assumptions made
above is that both enzymes act distributively. An alternative
hypothesis is that one or the other of the enzymes acts pro-
cessively, allowing more than one modiﬁcation to be made in
each molecular encounter. Suppose given a kinase, phos-
phatase, substrate system with two phosphorylation sites, for
which a variety of steady states are constructed having dif-
ferent total amounts of substrate and enzymes and different
initial conditions and that, for each steady state, [S0][S2]/[S1]
2
is plotted against [S2]/[S1]. We show below (see Fig. 1) that if
both enzymes are distributive, the resulting graph is ﬂat; if
the kinase is distributive and the phosphatase is processive,
the graph increases linearly; if the kinase is processive and the
phosphatase distributive, the graph decreases hyperbolically;
and if both enzymes are processive, the graph has a mini-
mum, so that it ﬁrst decreases and then increases. It follows
that the mechanism of action of the enzymes can be deter-
mined by measurements carried out at steady state.
Extending this result to n . 2, or to systems that are not
sequential, is surprisingly difﬁcult and requires different
mathematical techniques. For instance, for a nonsequential
system with two sites, which corresponds to the case of sev-
eral interesting biological examples, the invariant is consid-
erably more complicated than Eq. 5 (see Eq. 16). We review
these issues in the Discussion along with the challenges of
experimentally verifying these predictions.
METHODS
The results were obtained by algebraic calculation. Fig. 1 was generated in
Mathematica (Wolfram Research, Champaign, IL).
THEORY
Proof of Eq. 3
Consider the enzymatic chain in Eq. 1 at steady state. Let ei
be the net ﬂux of substrate from Si to Si11 due to enzyme E
and let fi be the net ﬂux of substrate in the same direction due
to enzyme F. Since the system is at steady state, the net ﬂux
into Si11 from the left, given by ei  fi, must equal the net
ﬂux out of Si11 to the right, given by ei11  fi11. Hence ei 
fi ¼ ei11  fi11 for 0 # i , n. However, there is no net ﬂux
into S0 from the left, nor net ﬂux out of Sn to the right.
(Sequentiality is essential here.) It follows that ei¼ fi for 0#
i, n. In other words, at steady state, each individual loop in
the chain is at steady state. This observation, which has been
repeatedly made in different mathematical contexts, is well
known to experts in biochemical kinetics (20).
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The net ﬂuxes are given by ei ¼ cEi ½ESi and fi ¼ cFi11
½FSi11: It follows from Eq. 2 that at steady state, cXi ½XSi ¼
aXi ½X½Si  bXi ½XSi; so that
½XSi ¼ ½X½Si
K
X
i
: (6)
Since ei ¼ fi,
c
E
i
½E½Si
KEi
¼ cFi11
½F½Si11
KFi11
;
from which Eq. 3 follows.
Model of processive phosphorylation
and dephosphorylation
Consider the case n ¼ 2. We explain the difﬁculties with the
general case in the Discussion. If E acts processively, then it
only makes a difference to its phosphorylation of S0. We
assume the following reaction scheme,
(7)
in which the decision as to how many phosphorylations to
undertake is determined after binding of substrate molecule
and kinase molecule. This is consistent with the experimental
intuition emerging from studies of processive phosphoryl-
ation (21). It is conceivable that the decision could be made
earlier, during the binding event, which would lead to a
different reaction scheme, but it makes no difference to our
results (not shown).
The different possibilities for product formation in Eq. 7
each have their own mass-action rate constants, cE0;1 and c
E
0;2:
If cE0;2 ¼ 0; then the scheme reverts to that in Eq. 2 for a
distributive kinase. We assume a symmetrical scheme to Eq.
7 for the processive dephosphorylation of S2, with catalytic
rate constants cF2;1 and c
F
2;0: If c
F
2;0 ¼ 0 then the phosphatase
reverts to being distributive.
We further assume that either cE0;1 6¼ 0 or cF2;1 6¼ 0; for if
both are zero then there is no way to produce S1. The case of
full processivity for both enzymes (that is, when exactly two
modiﬁcations are done in each molecular encounter, so that
cE0;1 ¼ cF2;1 ¼ 0) can be easily handled, since it is equivalent
to having only a single site. We will ignore this possibility
here. It is in any case more reasonable to assume that full
processivity means that the single modiﬁcation rate is very
small compared to the double modiﬁcation rate, so that
cE0;1=c
E
0;2  1 for the kinase and cF2;1=cF2;0  1 for the phos-
phatase and these conditions can be handled by the results
below.
Steady-state analysis
We will calculate [S0][S2]/[S1]
2, assuming both kinase and
phosphatase are processive, as described in Eq. 7. Because of
the ﬂux from S0 to S2 implied by this, the simple argument
for the distributive case can no longer be used. However,
balancing the net ﬂuxes at S0 at steady state in a similar way,
we see that
ðcE0;11 cE0;2Þ½ES0 ¼ cF1 ½FS11 cF2;0½FS2: (8)
If the deﬁnitions of the Michaelis-Menten constants KE0 and
KF2 are slightly modiﬁed so that
FIGURE 1 Distinguishing distributive from processive.
Plots of [S0][S2]/[S1]
2 against [S2]/[S1] for systems with
catalytic constants andMichaelis-Menten constants all 1, as
described in the text. (A) Kinase distributive, phosphatase
distributive. The constant value is the ratio of the relative
catalytic efﬁciencies at the two sites, l1/l0. (B) Kinase
distributive, phosphatase processive. The slope increases
with the degree of processivity of the phosphatase. (C) Ki-
nase processive, phosphatase distributive. The position of
the singularity moves to the right as the degree of pro-
cessivity of the kinase increases. (D) Kinase processive,
phosphatase processive. The position of the singularity and
of the minimum, along with the value of the minimum,
determine the parameters in Eq. 15.
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K
E
0 ¼ ðbE0 1 cE0;11 cE0;2Þ=aE0 and KF2 ¼ ðbF21 cF2;11 cF2;0Þ=aF2 ;
then it can be checked that Eq. 6 continues to hold for X¼ E,
0 # i , 2 or X ¼ F, 0 , i # 2. Hence, Eq. 8 gives
c
E
0;11 c
E
0;2
KE0
½E½S0 ¼ c
F
1
KF1
½F½S11
c
F
2;0
KF2
½F½S2;
which may be rearranged to give
½S0
½S1 ¼
cE0;11 c
E
0;2
K
E
0
 !1
c
F
1
K
F
1
1
cF2;0
K
F
2
½S2
½S1
 !
½F
½E: (9)
A similar balancing of steady-state ﬂuxes at S2 gives a
formula symmetric to Eq. 9 with subscript 0 interchanged
with 2 and E interchanged with F:
½S2
½S1 ¼
c
F
2;11 c
F
2;0
K
F
0
 !1
cE1
K
E
1
1
c
E
0;2
K
E
0
½S0
½S1
 !
½E
½F: (10)
Equations 9 and 10 are a pair of simultaneous linear equa-
tions for [S2]/[S1] and [S0][S1] in terms of the rate constants
and [E]/[F]. To solve them, it is convenient to introduce
relative catalytic efﬁciencies similar to li in Eq. 4,
l0 ¼
c
E
0;11 c
E
0;2
K
E
0
 !
c
F
1
K
F
1
 1
l1 ¼
c
E
0;11 c
E
0;2
KE0
 !
c
F
2;0
KF2
 !1
l1 ¼ c
E
1
KE1
 
c
F
2;11 c
F
2;0
KF2
 !1
l ¼
c
E
0;2
K
E
0
 !
c
F
2;11 c
F
2;0
K
F
2
 !1
: (11)
When the kinase is distributive, so that cE0;2 ¼ 0; l0 as
deﬁned in Eq. 11 reduces to l0 as deﬁned in Eq. 4 for the
distributive case and similarly for l1 when the phosphatase is
distributive. The parameters l1 and l are speciﬁc to the
processive case. Since we have assumed that either cE0;1 6¼ 0
or cF2;1 6¼ 0; it follows that l1 . l.
Solving for [S2]/[S1] and [S0][S1] in Eqs. 9 and 10, we ﬁnd
that
½S0
½S1 ¼
l1
l1  l
1
l0
½F
½E1
l1
l1
 
½S2
½S1 ¼
l1
l1  l l1
½E
½F1
l
l0
 
; (12)
from which it follows that
½S0½S2
½S12
¼ 1 l
l1
 2 ðl1Þ2
l1
½E
½F1
l
ðl0Þ2
½F
½E

1
l1
l0
1 l
l1
 
:
(13)
Distinguishing distributive from processive
Equation 13 provides a way to distinguish between the four
possibilities for the mechanism of action of E and F.
However, although the experimentalist can control [Etot],
[Ftot], and [Stot] and measure [S0], [S1], and [S2], the
quantities [E] and [F] are determined by the dynamics of the
system and cannot readily be measured or controlled. The
second formula in Eq. 12 shows that [E]/[F] is a linear
function of [S2]/[S1] and the latter can be measured. To
exploit this, it is helpful to further simplify the algebra. Let
a ¼ 1 l
l1
; k ¼ l
l0
; r ¼ l1
l1
; d ¼ l1
l0
: (14)
Note that 1  a ¼ kr/d. If the kinase is distributive then
cE0;2 ¼ 0; l ¼ 0, and k¼ 0; if the phosphatase is distributive
then cF2;0 ¼ 0; l1 ¼N, and r ¼ 0; since l1 . l, 0, a#
1 and if either kinase or phosphatase is distributive then a ¼
1; d reverts to the value that [S0][S2]/[S1]
2 has when both
enzymes are distributive. Let x ¼ [S2]/[S1]. Substituting for
[E]/[F] in terms of x in Eq. 13, we ﬁnd that
½S0½S2
½S12
¼ rax1 kd
ax  k1 dð2a 1Þ: (15)
Note from the second equation in Eq. 12 that ax  k . 0.
There are four cases to consider.
E distributive, F distributive
In this case k ¼ r ¼ 0 and a ¼ 1. Hence, [S0][S2]/[S1]2 ¼ d,
in accordance with Eq. 5. It does not change with x.
E distributive, F processive
In this case k¼ 0 and a¼ 1. Hence, [S0][S2]/[S1]2¼ rx1 d,
which increases linearly with x. When graphed, this gives a
straight line whose intercept on the vertical axis is d, the
value that [S0][S2]/[S1]
2 would have if F were distributive
with a catalytic rate of cF2;11c
F
2;0: The slope of the graph is
r ¼ c
E
1
KE1
c
E
0
KE0
 1
c
F
2;0
cF2;11 c
F
2;0
;
which increases hyperbolically with increasing cF2;0; the
catalytic rate for producing S0 from S2. In particular, no
matter how processive F is (that is, no matter how small
cF2;1=c
F
2;0 is), the slope of the graph cannot exceed the ratio of
the catalytic efﬁciencies of E at sites 1 and 0. If this latter
number can be estimated, then measurement of the slope
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gives an estimate of the degree of processivity of F, cF2;1=c
F
2;0:
In particular, full processivity of the phosphatase, where
cF2;1=c
F
2;0  1; can be detected.
E processive, F distributive
In this case, r ¼ 0 and a ¼ 1. Hence, [S0][S2]/[S1]2 ¼
kd/(x  k) 1 d. When graphed, this gives a hyperbola,
whose singularity occurs at
x ¼ k ¼ c
F
1
K
F
1
cF2
K
F
2
 1
c
E
0;2
c
E
0;11 c
E
0;2
:
This point increases hyperbolically with increasing cE0;2;
the catalytic rate for producing S2 for S0. In particular, it can
never exceed the ratio of the catalytic efﬁciencies of F at sites
1 and 2. If this number can be estimated, then measurement
of the position of the singularity gives an estimate of the
degree of processivity of the kinase, cE0;1=c
E
0;2: In particular,
full processivity, where cE0;1=c
E
0;2  1; can be detected. The
asymptote as x/N is d, the value that [S0][S2]/[S1]
2 would
have if E were distributive with a catalytic rate of cE0;11c
E
0;2:
E processive, F processive
In this case, the right-hand side of Eq. 15 deﬁnes a function
whose graph ﬁrst decreases as x increases away from x¼ k/a
but then increases as x/N: It has a singularity at x ¼ k/a
and a minimum at
x ¼ k
a
11
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ap
 
:
The ratio of the position of the minimum to the position of
the singularity gives an estimate of a, which then allows k
to be recovered. The minimum value is dða1 2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 ap Þ;
which allows d to also be estimated.
Provided a sufﬁciently broad range of [S2]/[S1] values can
be obtained by varying the total concentrations and initial
conditions then not only can the mechanisms of action of E
and F be deduced but values of the relevant compound
parameters in Eq. 14 can also be estimated, without the need
for any ﬁtting.
Fig. 1 shows the graphs of [S0][S2]/[S1]
2 against [S2]/[S1]
for four systems in which all nonzero catalytic constants are
1 and all Michaelis-Menten constants are 1 (units may be
chosen arbitrarily provided they are consistent between the
two sets of constants). When both enzymes are processive
the parameter values in Eq. 15 are
a ¼ 3
4
; k ¼ 3
8
; r ¼ 3
8
; d ¼ 9
16
:
Fig. 1 shows how easily the different cases can be dis-
tinguished by qualitative comparison and how the parame-
ters can be quickly estimated, as described above.
DISCUSSION
Experimental determination of distributivity or processivity
has been based on time course experiments. If the rate of
production of highly phosphorylated phospho-forms is un-
changed as the concentration of unphosphorylated sub-
strate is increased or if production of highly phosphorylated
phospho-forms cannot be interrupted by a competitor, that
provides evidence for a highly processive mechanism (21–
25). Although these methods can detect processivity, addi-
tional experiments are usually required at either end of the
processivity scale, when the system is distributive or fully
processive (22).
The method introduced in this article has several advan-
tages. 1), Only a single set of steady-state measurements is
required, using both kinase and phosphatase. If only one of
the enzymes is of interest, the other can be chosen arbitrarily.
2), It gives the mechanism of both kinase and phosphatase
simultaneously. 3), Classiﬁcation of the mechanisms is by
qualitative distinctions in the shapes of graphs, as in Fig. 1.
4), It does not require careful control of initial conditions or
concentrations, which may be chosen in any convenient way
to generate a broad range of [S2]/[S1] values. 5), It does not
require additional experiments at the distributive end of the
processivity scale, irrespective of the mechanism of the other
enzyme. 6), The degree of processivity of one of the enzymes
can be quantitatively determined without the need for any
ﬁtting, provided that site-speciﬁc catalytic efﬁciencies of the
other enzyme can be estimated. In this case, full processivity
of the ﬁrst enzyme can also be determined. 7), Once the site-
speciﬁc catalytic efﬁciencies have been estimated for one
standard kinase or phosphatase, they can be used in con-
junction with any cognate phosphatase or kinase, respec-
tively. 8), In all cases, the relevant compound parameters in
Eq. 15 can be estimated without the need for any ﬁtting.
The results of this article focus attention on two principles:
ﬁrst, the importance of studying multisite phosphorylation as
a system, with both kinase and phosphatase present. Al-
though this is always the case in vivo, in vitro studies, with
the notable exception of recent work in extracts (12), have
customarily focused on each enzyme individually. Second,
there are polynomial invariants at steady state, which encode
useful information about enzymemechanisms. Further devel-
opment of these ideas must confront both experimental and
theoretical challenges.
The experimenter must deal with two issues. First, as
mentioned, steady states need to be generated. Bringing
kinase and phosphatase together creates a futile cycle, which
churns ATP. The resulting buildup of ADP and inorganic
phosphate can poison the reactions, effectively compromis-
ing the biochemical scheme in Eq. 2. A similar problem is
experienced in high-throughput in vitro translation systems
for which a remedy was found by using reaction chambers
separated from a larger buffer volume by a dialysis mem-
brane, thereby allowing dilution of reaction products (26). In
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our laboratory, we are adapting a commercial in vitro
translation system for multisite phosphorylation studies,
which we expect to give improved reproducibility of steady
states.
Second, given a substrate with n sites, it is necessary to
distinguish and quantify all 2n potential phospho-forms.
Although antibodies are frequently used to detect phospho-
rylation, they can be ill-suited to distinguishing phosphor-
ylation patterns. For instance, Erk2 (the p42 MAP kinase) is
one of the most frequently studied phospho-proteins. It is
doubly phosphorylated on threonine (T) and tyrosine (Y) in a
three residue T-Y motif in its activation loop. Although
commercial antibodies exist to the intermediate phospho-
forms, (pT)-Y and T-(pY), we have found that they show
unacceptable cross-reactivity on quantitative Western blots.
(In contrast, antibodies against the maximally phosphory-
lated phospho-form, (pT)-(pY), and the unphosphorylated
substrate, T-Y, are much more speciﬁc.) Mass spectrometry
(MS) holds much promise for phospho-protein analysis
(7,10,27). One problem with MS, as with other forms of
protein separation such as isoelectric focusing, is that differ-
ent phospho-forms may have the same mass/charge ratios.
Moreover, since proteins must ﬁrst be digested into peptides,
even if the phospho-peptides can be distinguished, the
phospho-proteins still have to be deconvoluted from the
phospho-peptides. We believe that a combination of iso-
electric focusing, followed by high-performance liquid
chromatography and tandem MS, will be able to distinguish
and quantify all 2n phospho-forms on a substrate with n sites,
for low values of n. We are developing such a protocol in
collaboration with Hanno Steen.
On the theoretical side, it turns out to be surprisingly
awkward to extend the results of this article to n . 2 or to
nonsequential systems. The latter would be most useful ini-
tially, because, even for n ¼ 2, it brings important biological
examples within the scope of our methods.
Of the two assumptions made in our analysis, degrees of
processivity in posttranslational modiﬁcation are well at-
tested in the literature. Both distributive and processive
enzymes are known and these properties can signiﬁcantly
impact cellular regulation (14,28,29). Phosphorylation of
Erk2 by the MAP kinase kinase Mek is distributive (22,23),
as is dephosphorylation of Erk2 by the phosphatase MKP3
(30). The p38 MAP kinase also doubly phosphorylates the
transcription factor ATF2 through a distributive mechanism
(31). Phosphorylation of p130Cas on 15 sites by Src appears
highly processive (24), as does phosphorylation of the
alternative splicing factor ASF/SF2 on nine sites by serine-
arginine protein-speciﬁc kinase SRPK1 (25). Phosphorylation
of the phosphate regulator Pho4 on ﬁve sites by the Cyclin-
CDK complex Pho80-Pho85 is partially processive, with an
average of 2.1 phosphorylations per molecular encounter
(21).
The other assumption, of sequentiality, has been less
well documented. This assumption is commonly made in
theoretical studies of multisite phosphorylation (14–18,32)
(a recent exception being Salazar and Ho¨fer (33)). Sequential
kinases are certainly known. For instance, GSK3, in its mode
of primed phosphorylation, phosphorylates SXXXS repeat
motifs on several substrates in a strict C to N order (34). The
receptor tyrosine kinase FGFR1 also auto-phosphorylates in
a strict order (35). These examples suggest that cognate
phosphatases may cooperate to maintain a sequential system
of kinase, phosphatase, and substrate. However, no such
phosphatase is currently known.
Nonsequential systems are more difﬁcult to analyze be-
cause the calculations required are nonlinear. In broad terms,
methods of algebraic geometry, rather than linear algebra,
are needed. In joint work with Arjun Manrai, we have been
able to show that a two-site system in which both kinase and
phosphatase are distributive has the following invariant:
a½S0121 b½S01½S101 c½S102 ¼ d½S00½S11; (16)
where the subscript on S indicates which sites are phosphor-
ylated and a, b, c, and d depend only on the rate constants.
However, it remains unclear how this changes when one or
both of the enzymes is processive and whether that change
can be used to determine the degree of processivity. Erk2 is
phosphorylated on its two activating sites by Mek and
dephosphorylated by MKP3, both of which are known to be
distributive, as mentioned above. The Mek, MKP3, Erk2
system would therefore provide a test of Eq. 16, provided the
experimental issues discussed above can be resolved.
The case n . 2 presents similar difﬁculties. The steady-
state equations corresponding to Eqs. 9 and 10 are no longer
linear in the [Si11]/[Si] and their reciprocals. Furthermore,
with increasing numbers of sites, the nature of the pro-
cessivity becomes more complicated. Is there a processivity
bound, so that no more than k modiﬁcations are made in any
encounter? If the system is nonsequential, can any pattern of
modiﬁcations be made or does this depend on the pattern of
modiﬁcations already made? Such questions can only be
answered by detailed experiments on speciﬁc kinase, phos-
phatase, substrate systems. This is work in progress in our
laboratory.
Multisite protein phosphorylation and dephosphorylation
are key cellular regulatory mechanisms. We hope that the
results of this article will encourage both theoreticians and
experimentalists to further unravel their emergent complexity.
We thank the editor and two anonymous reviewers for their helpful
comments and Hanno Steen and Arjun Manrai for permission to mention
results from unpublished joint work.
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